Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

5259028cc04f2.LLvB_dTECodj1C1UmA9_LjD9_HFHre_ndSVlFuV4DgU.Vcqkrouhf7FUuR9g7UsKHkKlmjwf2LylM0gsWbwQR3AY35if-bFB4DX5Xg~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +62.43%
+7.22%
+10.09%
-0.03%
+1.02%
+10.39%
-0.24%
+27.41%
-7.05%
+4.63%
Average +11.59%
Weighted average by Cap. +6.27%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
313.98PKR
Average target price
510.00PKR
Spread / Average Target
+62.43%
High Price Target
510.00PKR
Spread / Highest target
+62.43%
Low Price Target
510.00PKR
Spread / Lowest Target
+62.43%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited